Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab. (Record no. 24332370)

MARC details
000 -LEADER
fixed length control field 02520 a2200685 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517001952.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201507s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1949-2553
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.18632/oncotarget.2163
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Falchook, Gerald S
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150730
245 00 - TITLE STATEMENT
Title Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Oncotarget
Date of publication, distribution, etc. Nov 2014
300 ## - PHYSICAL DESCRIPTION
Extent 10280-92 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bevacizumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Boronic Acids
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bortezomib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Renal Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fatigue
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypoxia-Inducible Factor 1, alpha Subunit
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kidney Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Magnetic Resonance Imaging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Staging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neovascularization, Pathologic
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proteasome Endopeptidase Complex
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thrombocytopenia
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vascular Endothelial Growth Factor A
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vascular Endothelial Growth Factor Receptor-2
General subdivision metabolism
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wheler, Jennifer J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Naing, Aung
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jackson, Edward F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Janku, Filip
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hong, David
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ng, Chaan S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tannir, Nizar M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lawhorn, Kristie N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huang, Mei
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Angelo, Laura S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vishwamitra, Deeksha
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hess, Kenneth
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Howard, Adrienne N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Parkhurst, Kristin L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Amin, Hesham M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kurzrock, Razelle
773 0# - HOST ITEM ENTRY
Title Oncotarget
Related parts vol. 5
-- no. 21
-- p. 10280-92
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.18632/oncotarget.2163">https://doi.org/10.18632/oncotarget.2163</a>
Public note Available from publisher's website

No items available.